Literature DB >> 24042210

Postural orthostatic tachycardia syndrome (POTS).

Bharat Sidhu1, Nonyelum Obiechina, Noman Rattu, Shanta Mitra.   

Abstract

Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous group of conditions characterised by autonomic dysfunction and an exaggerated sympathetic response to assuming an upright position. Up till recently, it was largely under-recognised as a clinical entity. There is now consensus about the definition of POTS as a greater than 30/min heart rate increase on standing from a supine position (greater than 40/min increase in 12-19-year-old patients) or an absolute heart rate of greater than 120/min within 10 min of standing from a supine position and in the absence of hypotension, arrhythmias, sympathomimetic drugs or other conditions that cause tachycardia. We present two cases of POTS, followed by a discussion of its pathogenesis, pathophysiology, epidemiology and management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24042210      PMCID: PMC3794314          DOI: 10.1136/bcr-2013-201244

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Endurance exercise training in orthostatic intolerance: a randomized, controlled trial.

Authors:  Robert Winker; Alfred Barth; Daniela Bidmon; Ivo Ponocny; Michael Weber; Otmar Mayr; David Robertson; André Diedrich; Richard Maier; Alex Pilger; Paul Haber; Hugo W Rüdiger
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

2.  Postural tachycardia syndrome.

Authors:  Blair P Grubb
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

3.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Authors:  Roy Freeman; Wouter Wieling; Felicia B Axelrod; David G Benditt; Eduardo Benarroch; Italo Biaggioni; William P Cheshire; Thomas Chelimsky; Pietro Cortelli; Christopher H Gibbons; David S Goldstein; Roger Hainsworth; Max J Hilz; Giris Jacob; Horacio Kaufmann; Jens Jordan; Lewis A Lipsitz; Benjamin D Levine; Phillip A Low; Christopher Mathias; Satish R Raj; David Robertson; Paola Sandroni; Irwin J Schatz; Ron Schondorf; Julian M Stewart; J Gert van Dijk
Journal:  Auton Neurosci       Date:  2011-03-09       Impact factor: 3.145

4.  Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome.

Authors:  N Muenter Swift; N Charkoudian; R M Dotson; G A Suarez; P A Low
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-29       Impact factor: 4.733

5.  Vascular responses to orthostatic stress in patients with postural tachycardia syndrome (POTS), in patients with low orthostatic tolerance, and in asymptomatic controls.

Authors:  V E Bush; V L Wight; C M Brown; R Hainsworth
Journal:  Clin Auton Res       Date:  2000-10       Impact factor: 4.435

6.  Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome.

Authors:  V M Gordon; T L Opfer-Gehrking; V Novak; P A Low
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

7.  The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone.

Authors:  B Davies; R Bannester; P Sever; C Wilcox
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

Review 8.  Postural tachycardia syndrome (POTS).

Authors:  Phillip A Low; Paola Sandroni; Michael Joyner; Win-Kuang Shen
Journal:  J Cardiovasc Electrophysiol       Date:  2009-01-16

9.  Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.

Authors:  Satish R Raj; Bonnie K Black; Italo Biaggioni; Sachin Y Paranjape; Maricelle Ramirez; William D Dupont; David Robertson
Journal:  Circulation       Date:  2009-08-17       Impact factor: 29.690

Review 10.  Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.

Authors:  S Sulfi; A D Timmis
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

View more
  4 in total

1.  Is ivabradine a wonder drug for atypical POTS?

Authors:  Muhammad Arslan Cheema; Muhammad Abdullah Zain; Waqas Ullah; Khadija Cheema
Journal:  BMJ Case Rep       Date:  2019-04-20

2.  Baroreflex Sensitivity Predicts Short-Term Outcome of Postural Tachycardia Syndrome in Children.

Authors:  Hongxia Li; Ying Liao; Yuli Wang; Ping Liu; Chufan Sun; Yonghong Chen; Chaoshu Tang; Hongfang Jin; Junbao Du
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

3.  Sleep disturbance linked to suicidal ideation in postural orthostatic tachycardia syndrome.

Authors:  Cathy Lynn Pederson; Jill Blettner Brook
Journal:  Nat Sci Sleep       Date:  2017-04-12

4.  Postural orthostatic tachycardia syndrome as a sequela of COVID-19.

Authors:  Cameron K Ormiston; Iwona Świątkiewicz; Pam R Taub
Journal:  Heart Rhythm       Date:  2022-07-16       Impact factor: 6.779

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.